Brief: Mayne Pharma Enters Into Scheme Implementation Deed With Cosette Pharmaceuticals
Feb 21 (Reuters) - Mayne Pharma Group Ltd MYX.AX :
* ENTERS INTO A SCHEME IMPLEMENTATION DEED WITH COSETTE
PHARMACEUTICALS, INC
* ACQUISITION PRICE OF A$7.40 PER SHARE IN CASH
* BOARD UNANIMOUSLY RECOMMENDS SHAREHOLDERS VOTE IN FAVOUR
OF
SCHEME IN ABSENCE OF A SUPERIOR PROPOSAL
Further company coverage: MYX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)